Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and is divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

Certificate, Healthcare Management , Rice University
Fellow , Harvard University Alley-Sheridan School of Government
Residency , Texas Heart Institute
Residency , Baylor College of Medicine
MD , Baylor College of Medicine

Surgical Removal and Replacement of Chronically Implanted Transcatheter Aortic Prostheses: How I Teach It
Mangi, AA, Ramchandani, M & Reardon, M 2018, Annals of Thoracic Surgery, vol 105, no. 1, pp. 12-14. DOI: 10.1016/j.athoracsur.2017.08.015

Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial
Baron, SJ, Arnold, SV, Reynolds, MR, Wang, K, Deeb, M, Reardon, MJ, Hermiller, J, Yakubov, SJ, Adams, DH, Popma, JJ, Cohen, DJ & US CoreValve Investigators 2017, American Heart Journal, vol 194, pp. 39-48. DOI: 10.1016/j.ahj.2017.08.006

Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease
Crestanello, JA, Popma, JJ, Adams, DH, Deeb, GM, Mumtaz, M, George, B, Huang, J & Reardon, MJ 2017, JACC: Cardiovascular Interventions, vol 10, no. 22, pp. 2283-2293. DOI: 10.1016/j.jcin.2017.07.025

Will transcatheter aortic valve replacement echo surgical aortic valve replacement durability?
Little, SH & Reardon, MJ 2017, JAMA Cardiology, vol 2, no. 11, pp. 1206-1207. DOI: 10.1001/jamacardio.2017.3307

Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry
Sorajja, P, Kodali, S, Reardon, MJ, Szeto, WY, Chetcuti, SJ, Hermiller, J, Chenoweth, S, Adams, DH & Popma, JJ 2017, JACC: Cardiovascular Interventions, vol 10, no. 20, pp. 2090-2098. DOI: 10.1016/j.jcin.2017.07.027

Should TAVR Replace Surgery for Aortic Stenosis in Low- to Intermediate-Risk Patients?
Barker, CM & Reardon, MJ 2017, Canadian Journal of Cardiology, vol 33, no. 9, pp. 1124-1128. DOI: 10.1016/j.cjca.2017.06.013

Contemporary repair of type a aortic dissection
Auyang, PL, Bismuth, J & Reardon, MJ 2017, Italian Journal of Vascular and Endovascular Surgery, vol 24, no. 3, pp. 107-117. DOI: 10.23736/s1824-4777.17.01301-8

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings
Yoon, SH, Whisenant, BK, Bleiziffer, S, Delgado, V, Schofer, N, Eschenbach, L, Fujita, B, Sharma, R, Ancona, M, Yzeiraj, E, Cannata, S, Barker, C, Davies, JE, Frangieh, AH, Deuschl, F, Podlesnikar, T, Asami, M, Dhoble, A, Chyou, A, Masson, JB, Wijeysundera, HC, Blackman, DJ, Rampat, R, Taramasso, M, Gutierrez-Ibanes, E, Chakravarty, T, Attizzani, GF, Kaneko, T, Wong, SC, Sievert, H, Nietlispach, F, Hildick-Smith, D, Nombela-Franco, L, Conradi, L, Hengstenberg, C, Reardon, MJ, Kasel, AM, Redwood, S, Colombo, A, Kar, S, Maisano, F, Windecker, S, Pilgrim, T, Ensminger, SM, Prendergast, BD, Schofer, J, Schaefer, U, Bax, JJ, Latib, A & Makkar, RR 2017, Journal of the American College of Cardiology, vol 70, no. 9, pp. 1121-1131. DOI: 10.1016/j.jacc.2017.07.714

The authors reply
Reardon, MJ, Van Mieghem, NM & Popma, JJ 2017, New England Journal of Medicine, vol 377, no. 2, pp. 197-198. DOI: 10.1056/NEJMc1706234

Response to mr bapat: does size matter? it does in texas
Reardon, MJ 2017, Journal of Thoracic and Cardiovascular Surgery, vol 154, no. 1, pp. 59-60. DOI: 10.1016/j.jtcvs.2017.03.117

Association between hospital volume and 30-day readmissions following transcatheter aortic valve replacement
Khera, S, Kolte, D, Gupta, T, Goldsweig, A, Velagapudi, P, Kalra, A, Tang, GHL, Aronow, WS, Fonarow, GC, Bhatt, DL, Aronow, HD, Kleiman, NS, Reardon, M, Gordon, PC, Sharaf, B & Abbott, JD 2017, JAMA Cardiology, vol 2, no. 7, pp. 732-741. DOI: 10.1001/jamacardio.2017.1630

Transcatheter Aortic Valve Replacement for Perceval Sutureless Aortic Valve Failure
Kalra, A, Reyes, M, Yang, EY, Little, SH, Nabi, F, Barker, CM, Ramchandani, M, Reul, RM, Reardon, MJ & Kleiman, NS 2017, Journal of Invasive Cardiology, vol 29, no. 6, pp. E65-E66.

1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses
Deeb, GM, Chetcuti, SJ, Reardon, MJ, Patel, HJ, Grossman, PM, Schreiber, T, Forrest, JK, Bajwa, TK, OHair, DP, Petrossian, G, Robinson, N, Katz, S, Hartman, A, Dauerman, HL, Schmoker, J, Khabbaz, K, Watson, DR, Yakubov, SJ, Oh, JK, Li, S, Kleiman, NS, Adams, DH & Popma, JJ 2017, JACC: Cardiovascular Interventions, vol 10, no. 10, pp. 1034-1044. DOI: 10.1016/j.jcin.2017.03.018

The use of transcatheter mitral valve system: Can we make mitral regurgitation better again?
Chamsi-Pasha, MA, Little, SH & Reardon, MJ 2017, Journal of Thoracic Disease, vol 9, no. 5, pp. 1174-1177. DOI: 10.21037/jtd.2017.04.70

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
Reardon, MJ, Van Mieghem, NM, Popma, JJ, Kleiman, NS, Søndergaard, L, Mumtaz, M, Adams, DH, Deeb, GM, Maini, B, Gada, H, Chetcuti, SJ, Gleason, TG, Heiser, J, Lange, R, Merhi, W, Oh, JK, Olsen, PS, Piazza, N, Williams, M, Windecker, S, Yakubov, SJ, Grube, E, Makkar, RR, Lee, JS, Conte, J, Vang, E, Nguyen, H, Chang, Y, Mugglin, AS, Serruys, PWJC, Kappetein, AP & SURTAVI Investigators 2017, The New England journal of medicine, vol 376, no. 14, pp. 1321-1331. DOI: 10.1056/NEJMoa1700456

Transcatheter Aortic Valve Replacement: How I Teach It
Reul, RM & Reardon, MJ 2017, Annals of Thoracic Surgery, vol 103, no. 3, pp. 695-698. DOI: 10.1016/j.athoracsur.2017.01.023

Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study
Popma, JJ, Reardon, MJ, Khabbaz, K, Harrison, JK, Hughes, GC, Kodali, S, George, I, Deeb, GM, Chetcuti, S, Kipperman, R, Brown, J, Qiao, H, Slater, J & Williams, MR 2017, JACC: Cardiovascular Interventions, vol 10, no. 3, pp. 268-275. DOI: 10.1016/j.jcin.2016.08.050

Reply: TAVR: Risk Models, Mortality Scoring, and Geriatric Assessment
Hermiller, JB, Reardon, MJ & Popma, JJ 2017, Journal of the American College of Cardiology, vol 69, no. 4. DOI: 10.1016/j.jacc.2016.10.070

Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis
Harrison, JK, Hughes, GC, Reardon, MJ, Stoler, R, Grayburn, P, Hebeler, R, Liu, D, Chang, Y & Popma, JJ 2017, JACC: Cardiovascular Interventions, vol 10, no. 2, pp. 168-175. DOI: 10.1016/j.jcin.2016.11.002

Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center
Kalra, A, Rehman, H, Ramchandani, M, Barker, CM, Lawrie, GM, Reul, RM, Reardon, MJ & Kleiman, NS 2017, Journal of Thoracic and Cardiovascular Surgery. DOI: 10.1016/j.jtcvs.2017.05.044